All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Fluorescein isothiocyanate (FITC) is a synthetic dye that is physiologically deficient in human body and has been used widely as a flowcytometry marker to label antibodies. The anti-FITC CAR contains two essential elements, one is a FITC-tagged tumor-targeting switch molecule and the other is a transmembrane CAR with an anti-FITC scFv. The FITC-labeled switch molecules form a pseudo-immunological synapse between anti-FITC CAR T cells and tumor cells expressing a given antigen, such as folate receptor or CD19, leading to lysis of the corresponding tumor cells.
Creative Biolabs provides customized Anti-FITC CAR design and construction services. Please contact us for more detailed information.
There are currently no customer reviews or questions for A uniCAR [Anti-FITC scFv-41BB-CD3ζ], with a CAR Adaptor [Anti-Mesothelin Antibody (H4H1657N2), FITC Labled], a Anti-FITC CAR System (CAR-NR-ZP1476). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION